Heron I - Search Results

1

Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine.

Fusco PC, Michon F, Laude-Sharp M, Minetti CA, Huang CH, Heron I, Blake MS. Fusco PC, et al. Among authors: heron i. Vaccine. 1998 Nov;16(19):1842-9. doi: 10.1016/s0264-410x(98)00174-1. Vaccine. 1998. PMID: 9795390

2

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults.

Richmond P, Goldblatt D, Fusco PC, Fusco JD, Heron I, Clark S, Borrow R, Michon F. Richmond P, et al. Among authors: heron i. Vaccine. 1999 Nov 12;18(7-8):641-6. doi: 10.1016/s0264-410x(99)00276-5. Vaccine. 1999. PMID: 10547423 Clinical Trial.

3

Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein.

Michon F, Fusco PC, Minetti CA, Laude-Sharp M, Uitz C, Huang CH, D'Ambra AJ, Moore S, Remeta DP, Heron I, Blake MS. Michon F, et al. Among authors: heron i. Vaccine. 1998 Nov;16(18):1732-41. doi: 10.1016/s0264-410x(98)00225-4. Vaccine. 1998. PMID: 9778749 Free article.

4

Booster vaccination against diphtheria and tetanus in man. Comparison of calcium phosphate and aluminium hydroxide as adjuvants--II.

Aggerbeck H, Fenger C, Heron I. Aggerbeck H, et al. Among authors: heron i. Vaccine. 1995 Oct;13(14):1366-74. doi: 10.1016/0264-410x(94)00082-x. Vaccine. 1995. PMID: 8585295 Clinical Trial.

5

Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.

Petersen JW, Andersen P, Ibsen PH, Capiau C, Wachmann CH, Hasløv K, Heron I. Petersen JW, et al. Among authors: heron i. Vaccine. 1993;11(4):463-72. doi: 10.1016/0264-410x(93)90289-a. Vaccine. 1993. PMID: 8470432

6

Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.

Aggerbeck H, Heron I. Aggerbeck H, et al. Among authors: heron i. Vaccine. 1995 Oct;13(14):1360-5. doi: 10.1016/0264-410x(94)00081-w. Vaccine. 1995. PMID: 8585294

7

Quantification of pertussis toxin, filamentous haemagglutinin, 69 kDa outer membrane protein, agglutinogens 2 and 3 and lipopolysaccharide in the Danish whole-cell pertussis vaccine.

Ibsen PH, Petersen JW, Heron I. Ibsen PH, et al. Among authors: heron i. Vaccine. 1993;11(3):318-22. doi: 10.1016/0264-410x(93)90193-2. Vaccine. 1993. PMID: 8447160

8

Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III.

Aggerbeck H, Wantzin J, Heron I. Aggerbeck H, et al. Among authors: heron i. Vaccine. 1996 Sep;14(13):1265-72. doi: 10.1016/s0264-410x(96)00092-8. Vaccine. 1996. PMID: 8961516 Clinical Trial.

9

Intranasal booster vaccination against diphtheria and tetanus in man.

Aggerbeck H, Gizurarson S, Wantzin J, Heron I. Aggerbeck H, et al. Among authors: heron i. Vaccine. 1997 Feb;15(3):307-16. doi: 10.1016/s0264-410x(96)00175-2. Vaccine. 1997. PMID: 9139491 Clinical Trial.

10

Synergistic teratogenic effect produced in mice by whole cell pertussis vaccine.

Au-Jensen M, Heron I. Au-Jensen M, et al. Among authors: heron i. Vaccine. 1987 Sep;5(3):215-8. doi: 10.1016/0264-410x(87)90103-4. Vaccine. 1987. PMID: 3673208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters